ZAI Lab

PharmaceuticalsSeries CShanghai, Chinazailaboratory.com

Latest round

Series C

Last raised

Jun 2017

Total raised

$160M

Investors

9

About ZAI Lab

S. As of March 31, 2022, ZAI Lab has more than 1,999 employees. In September 2020, it was listed on the Hong Kong Stock Exchange with stock code 9688. In September 2017, it completed USD 172 million NASDAQ IPO. The founder and CEO, Samantha Du, used to serve on the boards at Sequoia Capital China and led four healthcare investments. The company focused on bringing medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders. The products include ZEJULA (niraparib), Tumor Treating Fields (TTFields) therapy, QINLOCK (ripretinib), and NUZYRA (omadacycline). The clinical development team currently manages more than 50 ongoing or planned clinical trials. The company will use the funds to complete clinical trials and advance new drug candidates, support new business development and licensing opportunities, and expand commercialization operations.

Who invested in ZAI Lab

9 investors across 4 rounds

See all investors in ZAI Lab

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jun 28, 2017

    Amount

    $30M

    Investors

    Locked

  2. Series B

    Jan 8, 2016

    Amount

    $100M

    Investors

    Locked

  3. Series A

    Apr 1, 2015

    Amount

    Undisclosed

    Investors

    Locked

  4. Series A

    Aug 27, 2014

    Amount

    $30M

    Investors

    Locked

Questions about ZAI Lab

Who invested in ZAI Lab?

ZAI Lab has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ZAI Lab raised?

ZAI Lab has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did ZAI Lab last raise money?

ZAI Lab's most recent round on record is a Series C, in Jun 2017.

What does ZAI Lab do?

ZAI Lab is a pharmaceuticals company.

Where is ZAI Lab headquartered?

ZAI Lab is headquartered in Shanghai, China.

Which VCs invest in companies like ZAI Lab?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at ZAI Lab's stage. Their profiles are linked below.

Raising like ZAI Lab? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.